01 AUROBINDO PHARMA ITALIA Srl (4)
02 Accord Healthcare Ltd. (4)
03 Actavis Group hf. (4)
04 Actavis Switzerland AG (4)
05 Baxalta Innovations GmbH (1)
06 FRESENIUS KABI ONCOLOGY PLC (8)
07 Fresenius Kabi (Schweiz) AG (4)
08 HOSPIRA ITALIA Srl (3)
09 Hospira UK Limited (3)
10 Labatec Pharma SA (3)
11 MYLAN SpA (3)
12 PFIZER LTD (SANDWICH UK) (3)
13 Pfizer AG (3)
14 SANDOZ GMBH (3)
15 Sandoz Pharmaceuticals AG (8)
16 Teva Pharma AG (2)
17 The Fresenius Kabi Oncology Plc (8)
01 Irinotecan (44)
02 Irinotecan Hydrochloride (24)
01 Italy (24)
02 Norway (20)
03 Switzerland (24)
01 Concentrate to the infusion fluid (8)
02 Concentrate to the infusion fluid, resolution (12)
03 Infusion (24)
04 Irinotecan 100Mg 5Ml 1 Units Parenteral Use (7)
05 Irinotecan 300Mg 15Ml 1 Units Parenteral Use (5)
06 Irinotecan 40Mg 2Ml 1 Units Parenteral Use (6)
07 Irinotecan 40Mg 2Ml 5 Units Parenteral Use (1)
08 Irinotecan 500Mg 25Ml 1 Units Parenteral Use (5)